Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Viking Holdings (VIK) pulled back from recent highs, creating a mid-term dip-buy opportunity. Solid Q2 results, high booking curves (96% for 2026) and fleet-driven revenue growth underpin margins that deserve a premium. Enter at $79.88, stop at $72.00 and target $112.00 over a 45-trading-day swing - asymmetric upside with a defendable stop.
Realty Income faces acute pressure from the bond market, but the business fundamentals - long-duration leases, tenant diversification, monthly payout discipline and active capital recycling - argue for a measured long trade. Targeting a rebound as rate volatility normalizes, this idea lays out entry, stop and target with clear timeframes and risk c…
SeaStar Medical announced that data evaluating the post-approval SAVE Registry results for their FDA-approved QUELIMMUNE (SCD-PED) device will be presented as a late-breaking poster at ASN Kidney Week 2026. The company focuses on treatments for critically ill patients with organ failure, especially pediatric acute kidney injury (AKI) due to sepsis.…
Meta's AI wins and strong FCF mask valuation and technical vulnerabilities. With a market cap near $1.87T, P/E around 27x, stretched technicals and rising short-volume in late September, we see a viable mid-term short opportunity. Entry $730.00, stop $757.00, target $660.00 over ~45 trading days.
Climb Bio, a clinical-stage biotechnology company, will present new clinical data for its investigational drugs CLYM116 and budoprutug targeting immune-mediated kidney diseases at the American Society of Nephrology Kidney Week 2026. The data includes preliminary Phase 1 results for CLYM116 in healthy volunteers and Phase 2 data for budoprutug in pr…
newcleo plc announced its first-half 2026 financial and operational results following its business combination and Nasdaq listing under ticker NWCL. The company raised approximately $247 million through the SPAC merger and PIPE financing, plus additional funds, totaling over $1 billion raised since inception. Key operational advances include major …
Vera Therapeutics announced that the final efficacy analysis of its ORIGIN 3 trial for TRUTAKNA (atacicept-vymj) in treating IgA nephropathy will be highlighted in a late-breaking oral presentation at ASN Kidney Week 2026. Additional interim data from the Phase 2 PIONEER trial in glomerular diseases will also be presented. TRUTAKNA is the first app…
Decent Holding Inc., a Nasdaq-listed company specializing in wastewater treatment and senior health services in China, announced the pricing of a $1.23 million follow-on offering involving 822,828 Class A ordinary shares and associated warrants. The proceeds will support working capital and general corporate purposes. The securities offering is exp…
Anthropic's potential $2 trillion IPO is headline-grabbing but not obviously frothy once you bake in rapid enterprise adoption, subscription pricing, and margin capture. This trade buys a measured long exposure with a clear stop to protect against execution or regulatory shocks.
AppLovin (APP) has taken a beating after disclosure of AI development delays and a sharp sell-off in August. Fundamentals still point to robust growth, premium margins and strong cash generation. With technical oversold signals, elevated short interest and FCF of roughly $4.53B against a ~$92B market cap, the market appears to be pricing in a worst…
Artiva Biotherapeutics announced multiple data presentations at the American College of Rheumatology (ACR) Convergence 2026, featuring updated clinical results on its AlloNK® cell therapy combined with rituximab for treating refractory rheumatoid arthritis and other autoimmune diseases. The company also plans to initiate a Phase 3 registrational tr…
Broadcom's headline-driven pullback tied to Anthropic noise is disproportionate to the company's cash generation, hyperscaler relationships, and AI networking momentum. Valuation is elevated, but free cash flow and locked-in AI commitments give downside protection and upside on a normalization of sentiment.
Cuprina Holdings (Nasdaq: CUPR) announced it will acquire East Coast Podiatry and Orchard Clinic, a Singapore healthcare group operating seven clinics with FY2025 revenue of approximately S$9.1 million and EBITDA of S$1.2 million. The acquisition for about S$4 million (US$3.1 million) includes cash and company shares subject to lock-up and is expec…
Hall Chadwick Acquisition Corp. (NASDAQ: HCAC) and REEcycle Holdings, Inc. have jointly filed a registration statement on Form S-4 with the SEC relating to their proposed business combination. The filing includes a preliminary proxy statement/prospectus for shareholder approval and outlines next steps in the transaction process including mailing de…
Evaxion A/S, a clinical-stage TechBio company listed on NASDAQ, will present new immune data from its phase 2 trial of the AI-designed personalized cancer vaccine EVX-01 combined with pembrolizumab at the SITC 2026 Annual Meeting. The data highlight systemic immunomodulatory effects and durable clinical responses in advanced melanoma patients, foll…
ATA Creativity Global announced that it received a bid deficiency notice from Nasdaq due to its American Depositary Shares trading below the minimum required price of $1.00 for 31 consecutive business days. The company has until March 29, 2027, to regain compliance by raising its share price above $1.00 for 10 consecutive days. If not, it may seek …
All In FutureTech Alliance Inc. announced the launch of its AIFA Digital Service Platform, a bilingual AI-centered content and education hub designed to build long-term user engagement and progressively connect users to its education, workforce development, and global business services. The platform supports a dual digital strategy with the corpora…
iTonic Holdings Ltd, a China-based healthcare technology company listed on Nasdaq, announced a 16-for-1 share consolidation effective October 6, 2026, along with an increase in authorized share capital. This move aims to increase the trading price per share to meet Nasdaq's minimum $1.00 bid price requirement by the October 19, 2026 deadline. Despi…
MiNK Therapeutics announced new data presentations on their allogeneic invariant natural killer T (iNKT) cell therapies, including agenT-797 and MiNK-215, showing potential efficacy against checkpoint inhibitor-resistant colorectal cancer liver metastases and senescent tumor cells and fibroblasts. The data support ongoing clinical trials and highli…
Immuneering Corporation announced preclinical findings demonstrating that their drug candidate atebimetinib enhances PD-1 checkpoint blockade efficacy in RAS mutant tumor models. These results provide mechanistic rationale for an upcoming Phase 2 clinical trial testing atebimetinib combined with PD-1 inhibitors in lung cancer patients. The company …
Candel Therapeutics announced it will present promising clinical and mechanistic data from its lead immunotherapy candidates, aglatimagene besadenovec and linoserpaturev, at the SITC 41st Annual Meeting. The presentations highlight immune activation and improved survival in patients with progressive non-small cell lung cancer (NSCLC) despite prior …
ProKidney Corp., a clinical-stage biotechnology company focused on chronic kidney disease (CKD), announced it will present eight abstracts at the American Society of Nephrology's Kidney Week 2026. The presentations highlight translational and clinical data supporting the multifactorial mechanism of their lead cell therapy candidate, rilparencel, wh…
Fortinet, the global cybersecurity leader, announced it will hold a conference call on October 28, 2026, to discuss its third quarter financial results. The event will be accessible via the company's investor relations website, with prepared remarks and supplemental materials provided.
Rapid7, a NASDAQ-listed cybersecurity company, has introduced Rapid7 Intelligence, a unified AI-powered engine that transforms threat data into actionable defense strategies. This new platform shifts security from reactive monitoring to proactive prevention by analyzing attacker behaviors and delivering real-time, expert-validated insights to help …
Chicago Board of Trade wheat futures rose for a second day as a large Saudi Arabian import tender improved demand sentiment. Gains were capped by a strong dollar, while corn and soybeans moved lower on supply and harvest developments. Market participants are also watching upcoming U.S. jobs data for clues on interest rate direction.
